Select Page

KALY Conducts Cannabis Extraction Lab Site Survey For NOUV 100 Acer Hemp Farm

KALY Conducts Cannabis Extraction Lab Site Survey For NOUV 100 Acer Hemp Farm
609683.png

NOUV currently operates a 25-greenhouse growing operation and in partnership with KALY plans to build an additional state-of-the-art greenhouse for the purpose of developing a proprietary cannabis cultivar.

DALLAS, May 07, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced CEO Frederick Ferri is leading a site survey today of the cannabis extraction lab KALY is building in partnership with Nouveau (USOTC: NOUV) (“NOUV”) to facilitate extraction in conjunction with NOUV’s previously announced 100 acer hemp farm.

NOUV currently operates a 25-greenhouse growing operation and in partnership with KALY plans to build an additional state-of-the-art greenhouse for the purpose of developing a proprietary cannabis cultivar.

Patented Cannabis Extracts Targeting $170 In Million Pharmaceutical Treatments

Chronic Obstructive Pulmonary Disease (COPD) – The market for COPD treatment is anticipated to reach $14 billion by 2025;
Type 2 Diabetes – The market for Type 2 Diabetes is expected to be a $64 billion market by 2026;
Cancer Pain Management – The overall pain management treatment market is anticipated to reach $83 billion by 2024, and
Epilepsy – The market for epilepsy treatment is anticipated to reach $9 billion by 2022.

$1 Million 2019 Revenue Target From Parallel Revenue Strategy

Leave a Reply

avatar

Join Our Newsletter

Get stock alerts, news & related alerts straight to your inbox!